Xianzhi Mao

发表

Potent 2-[(pyrimidin-4-yl)amine}-1,3-thiazole-5-carbonitrile-based inhibitors of VEGFR-2 (KDR) kinase.

J. Shipman, N. Kohl, L. Sepp-Lorenzino, 2006, Bioorganic & medicinal chemistry letters.

Development of 6-substituted indolylquinolinones as potent Chek1 kinase inhibitors.

Michael Reilly, Laura Sepp-Lorenzino, Weikang Tao, 2006, Bioorganic & medicinal chemistry letters.

Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy.

S. Agrawal, Xianzhi Mao, Daqing Wang, 2018, International journal of oncology.

Immunohistochemical Detection of Antitumor, Antimetastasis, and Antiangiogenesis Effects of a Vascular Endothelial Growth Factor Receptor 2 Kinase Inhibitor in an Orthotopic Breast Cancer Metastasis Model

B. Connolly, J. Hardwick, N. Kohl, 2010 .

A Novel Orally Bioavailable Inhibitor of Kinase Insert Domain-Containing Receptor Induces Antiangiogenic Effects and Prevents Tumor Growth in Vivo

B. Connolly, D. Heimbrook, J. Shipman, 2004, Cancer Research.

Enhanced hindlimb collateralization induced by acidic fibroblast growth factor is dependent upon femoral artery extraction.

K. Thomas, E. Baskin, Xianzhi Mao, 2003, Cardiovascular research.

Potent N-(1,3-thiazol-2-yl)pyridin-2-amine vascular endothelial growth factor receptor tyrosine kinase inhibitors with excellent pharmacokinetics and low affinity for the hERG ion channel.

D. Heimbrook, J. Shipman, N. Kohl, 2004, Journal of medicinal chemistry.

Development of thioquinazolinones, allosteric Chk1 kinase inhibitors.

Laura Sepp-Lorenzino, Weikang Tao, Youwei Yan, 2009, Bioorganic & medicinal chemistry letters.

Synthesis and evaluation of substituted benzoisoquinolinones as potent inhibitors of Chk1 kinase.

Youwei Yan, S. Stirdivant, L. Kuo, 2007, Bioorganic & medicinal chemistry letters.

Optimization of a pyrazoloquinolinone class of Chk1 kinase inhibitors.

Lawrence C Kuo, Laura Sepp-Lorenzino, Weikang Tao, 2007, Bioorganic & medicinal chemistry letters.

3-(Indol-2-yl)indazoles as Chek1 kinase inhibitors: Optimization of potency and selectivity via substitution at C6.

Lawrence C Kuo, Laura Sepp-Lorenzino, Weikang Tao, 2006, Bioorganic & medicinal chemistry letters.

Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: effect of dexamethasone co-treatment.

S. Stirdivant, A. Sachs, J. Davide, 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

Dynamic contrast-enhanced MRI measurements of passive permeability through blood retinal barrier in diabetic rats.

K. Thomas, B. Berkowitz, Robin Roberts, 2004, Investigative ophthalmology & visual science.

Protein that binds to the distal, but not to the proximal, CCAAT of the human thymidine kinase gene promoter

M. Prystowsky, Xianzhi Mao, K. Lipson, 1995, Journal of cellular biochemistry.

Vascular Endothelial Growth Factor Receptor KDR Tyrosine Kinase Activity Is Increased by Autophosphorylation of Two Activation Loop Tyrosine Residues*

R. Hungate, R. Kendall, A. Tebben, 1999, The Journal of Biological Chemistry.

CCAAT‐box contributions to human thymidine kinase mRNA expression

M. Prystowsky, Xianzhi Mao, K. Lipson, 1995, Journal of cellular biochemistry.

Design and synthesis of 1,5-diarylbenzimidazoles as inhibitors of the VEGF-receptor KDR.

R. Hungate, R. Kendall, R. McFall, 2003, Bioorganic & medicinal chemistry letters.

Pyridyl aminothiazoles as potent Chk1 inhibitors: optimization of cellular activity.

S. Stirdivant, Weikang Tao, L. Sepp-Lorenzino, 2012, Bioorganic & medicinal chemistry letters.

Mechanistically probing lipid-siRNA nanoparticle-associated toxicities identifies Jak inhibitors effective in mitigating multifaceted toxic responses.

A. Sachs, Weikang Tao, J. Davide, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Abstract B094: Intratumoral administration of IMO-2125, a novel TLR9 agonist, modulates the tumor microenvironment and exerts systemic antitumor activity alone and in combination with an anti-CTLA-4 mAb

S. Agrawal, Xianzhi Mao, Daqing Wang, 2016 .

Brain-Imaging Evidence Sources of Mathematical Thinking : Behavioral and

R. Kendall, D. Szalkowski, G. Salituro, 2006 .

Sources of mathematical thinking: behavioral and brain-imaging evidence.

E. Spelke, S. Dehaene, P. Pinel, 1999, Science.

Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits

A. Bett, K. Thomas, E. Baskin, 2003, Heart and Vessels.

Discovery of a small molecule insulin mimetic with antidiabetic activity in mice.

R G Smith, D. Moller, J. Zierath, 1999, Science.

A position-dependent transcription-activating domain in TFIIIA

Xianzhi Mao, X. Mao, M. K. Darby, 1993, Molecular and cellular biology.

Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate.

K., Andrew, L. Soroceanu, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Dynamic contrast-enhanced MRI measurements of passive permeability through blood retinal barrier in diabetic rats.

K. Thomas, B. Berkowitz, Xianzhi Mao, 2004, Investigative ophthalmology & visual science.